In conclusion, our gel-like mPEG-Coa-based TRAIL delivery system could be utilized as a novel protein drug delivery platform to suppress the recurrence of residual cancer after cancer resection or chemotherapy by continuously supplying available TRAIL. Here, TNFSF10 is linked to cancer.